Zevenbergen Capital Investments’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q3
Sell
-495,575
Closed -$39.4M 87
2018
Q2
$39.4M Sell
495,575
-135,705
-21% -$11.3M 1.31% 29
2018
Q1
$56.3M Sell
631,280
-21,015
-3% -$2.02M 2.16% 20
2017
Q4
$68.1M Buy
652,295
+52,209
+9% +$5.89M 2.84% 13
2017
Q3
$87.5M Sell
600,086
-110,053
-15% -$15M 3.8% 9
2017
Q2
$92.2M Buy
710,139
+15,035
+2% +$1.84M 4.01% 8
2017
Q1
$86.5M Sell
695,104
-71,666
-9% -$8.58M 3.98% 7
2016
Q4
$88.8M Sell
766,770
-88,435
-10% -$9.85M 4.18% 7
2016
Q3
$89.4M Sell
855,205
-132,550
-13% -$14.3M 3.68% 9
2016
Q2
$97.4M Sell
987,755
-4,175
-0.4% -$432K 4.56% 6
2016
Q1
$99.3M Buy
991,930
+125,090
+14% +$12.9M 4.5% 6
2015
Q4
$104M Sell
866,840
-29,370
-3% -$3.4M 4.22% 5
2015
Q3
$96.9M Sell
896,210
-39,141
-4% -$4.86M 4.16% 5
2015
Q2
$108M Buy
935,351
+105,685
+13% +$12.1M 4.21% 6
2015
Q1
$95.6M Sell
829,666
-95,808
-10% -$11.4M 4% 6
2014
Q4
$104M Sell
925,474
-13,910
-1% -$1.47M 4.48% 5
2014
Q3
$89M Sell
939,384
-236,840
-20% -$21.4M 3.8% 7
2014
Q2
$101M Buy
1,176,224
+63,960
+6% +$4.86M 3.55% 10
2014
Q1
$77.6M Buy
1,112,264
+355,000
+47% +$28.1M 2.78% 11
2013
Q4
$64M Sell
757,264
-66,990
-8% -$5.3M 2.21% 18
2013
Q3
$63.5M Sell
824,254
-11,014
-1% -$772K 2.15% 17
2013
Q2
$48.9M Buy
+835,268
New +$50.3M 1.98% 23

Other funds holding CELG

Zevenbergen Capital Investments's CELG Position: Q3 2018 in Review

Zevenbergen Capital Investments sold out of Celgene Corp (CELG) in Q3 2018, closing a stake of 495,575 shares — an estimated $39.4M sold.

Zevenbergen Capital Investments first reported a position in CELG in Q2 2013 and held it in 21 quarters. The position peaked at $108M in Q2 2015. 1,364 funds tracked by Wall St. Rank hold CELG as of Q3 2018.

  • Zevenbergen Capital Investments reported no remaining Celgene Corp position as of Q3 2018 after selling out during the quarter.
  • Zevenbergen Capital Investments sold 495,575 Celgene Corp shares in Q3 2018, an estimated $39.4M.
  • Zevenbergen Capital Investments first reported a position in Celgene Corp in Q2 2013 and held it in 21 quarters.
  • Zevenbergen Capital Investments's Celgene Corp position peaked at $108M in Q2 2015.
  • 1,364 funds tracked by Wall St. Rank held Celgene Corp as of Q3 2018.

Based on Zevenbergen Capital Investments's 13F filing for Q3 2018, filed 13 Nov 2018.